Drugs / Bletilla formosana
Bletilla formosana
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07704944 | Jul 2026 → Jul 2027 expected | prediabetes syndrome | Chang Gung Memorial Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bletilla formosana | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07704944 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “a traditional herbal medicine” NCT07704944 ↗ |
| Route | Oral | “12 weeks of oral administration” NCT07704944 ↗ |